Trial intelligence / Profile preview

Phase II randomized double-blind placebo-controlled oral rotavirus vaccine study in young infants

ISRCTN86632774Phase 2Completed

Sponsor
World Health Organization
Start
Jan 2001
Modality
Vaccines & Immunotherapeutics
01

Overview

Phase 2, randomised, double-blind trial in rotaviral diarrhea comparing RIX4414 plus placebo schedule with Placebo control (2 arms). Primary endpoints: Anti-poliovirus type 1 seroprotection, Anti-poliovirus type 2 seroprotection and 1 more. Started Jan 2001; status: completed.

02

Drugs

human rotavirus RIX4414 strain vaccine
03

Conditions

rotaviral diarrhea

Beyond the preview

Go deeper on ISRCTN86632774.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN86632774.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call